Cargando…
Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders
BACKGROUND: Gold-standard psychological and pharmacological treatments for bulimic-spectrum eating disorders only result in remission for around 50% of patients; patients with affective lability and impulsivity represent a subgroup with particularly poor outcomes. Both dialectical behavior therapy (...
Autores principales: | Reilly, Erin E., Berner, Laura A., Trunko, Mary Ellen, Schwartz, Terry, Anderson, Leslie K., Krueger, Angeline, Yu, Xinze, Chen, Joanna Y., Cusack, Anne, Nakamura, Tiffany, Kaye, Walter H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123051/ https://www.ncbi.nlm.nih.gov/pubmed/35298791 http://dx.doi.org/10.1007/s40519-021-01320-3 |
Ejemplares similares
-
A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control
por: Trunko, Mary Ellen, et al.
Publicado: (2017) -
Changes in cognitive and behavioral control after lamotrigine and intensive dialectical behavioral therapy for severe, multi-impulsive bulimia nervosa: an fMRI case study
por: Berner, Laura A., et al.
Publicado: (2021) -
A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression
por: Schwartz, Terry, et al.
Publicado: (2021) -
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015) -
Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders
por: Nakamura, Tomoyuki, et al.
Publicado: (2022)